NCT00163332View on ClinicalTrials.gov

Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2003

Conditions
Asthma
Interventions
DRUG

Ciclesonide

Trial Locations (5)

3600

Altana Pharma/Nycomed, Genk

3620

Altana Pharma/Nycomed, Lanaken

4000

Altana Pharma/Nycomed, Liège

Altana Pharma/Nycomed, Liége

9000

Altana Pharma/Nycomed, Ghent

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY